WEL — Integrated Wellness Acquisition Income Statement
0.000.00%
Last trade - 00:00
- $81.64m
- $83.42m
- 56
- 27
- 60
- 45
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | 10-K | 10-K | 10-K |
Standards: | — | USG | USG | USG |
Status: | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | ||||
Other Operating Expenses | ||||
Total Operating Expenses | — | 0.146 | 1.12 | 2.5 |
Operating Profit | 0 | -0.146 | -1.12 | -2.5 |
Total Net Non Operating Interest Income / Expense | ||||
Net Income Before Taxes | — | -0.146 | 0.568 | 1.49 |
Net Income After Taxes | — | -0.146 | 0.568 | 1.49 |
Net Income Before Extraordinary Items | ||||
Net Income | — | -0.146 | 0.568 | 1.49 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Dilution Adjustment | ||||
Diluted Net Income | 0 | -0.146 | 0.568 | 1.49 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | — | -0.01 | 0.039 | 0.138 |